2024 CRO Market Size & Growth Projections

$750.00$1,500.00

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Report Overview

ISR’s analysis of the clinical development outsourcing industry is meant to provide insight into the constant questions, “What is the size of the CRO market?” and “What is the projected growth?” In this report, the data are segmented by geography, phase, and service line in order to generate a full picture of the outsourced clinical development services market.

Learn the estimated Research and Development (R&D) expenditures, the projected spending on Phase I-IV development, and outsourced Phase I-IV development, segmented by sponsor type: large pharma, non-large pharma, by molecule type (large and small), government, private, academic, and more. We use both data gathered through our syndicated primary market research efforts and publicly available information to generate this report.

The goal is to provide a view of the outsourced clinical development space while also grounding the reader in past developments to inform future projections. We take a top-down approach to understand what forces impact the overall CRO market. Welcome to the 2024 CRO Market Size & Growth Projections report.

 

What you will learn:

  • Projected spending on development, Phase I-IV development, and outsourced Phase I-IV development through 2028, segmented by sponsor type:
    • Large pharma – large molecule
    • Large pharma – small molecule
    • Non-large pharma – large molecule
    • Non-large pharma – small molecule
    • Generic/Specialty
    • Government
    • Private
    • Association/Non-profit
    • Academic
       
  • Spending on CRO services segmented by:
    • Geography
    • Service-line
    • Phase I-IV
       
  • Estimated R&D expenditures though 2028

 

Major Topics:

  • Current State of the CRO Market
  • SCDI – a stock index for pharma service providers
  • 2024 FY Expectations
  • 2023 Mergers and Acquisitions
  • Overall Market Size and Growth
  • R&D Sources and Distribution
  • Model Adjustments – from R&D to CRO Market Size
  • Development Spending
  • Phase I-IV Development Spending
  • Outsourced Phase I-IV Development Spending
  • CRO Market Size (2023-2028)
  • 2024 Geographic Analysis
  • 2024 Service-Line Analysis
  • 2024 Phase I, II, III, and IV analysis
  • 2023-2028 CRO Market Size Model

Questions?

Our team is here to help.

For questions about syndicated report purchases, custom research solutions, or other billing-related topics, please contact sales@ISRreports.com.